Roy C. Hardiman
Director, Pharmacyclics.
Companies
- ALUMIS INC.Chief Business & Legal Officer Jun 27, 2024 to now1
- Principia Biopharma (United States)Chief Business Officer Sep 13, 2018 to Sep 28, 20202
- PharmacyclicsBoard member Dec 13, 2010 to Oct 3, 20123
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ALUMIS INC. ALMS214,163 shares4$1.3M at $6.12Aug 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 3, 2026Sold 2,692 shares at $26.37 of ALUMIS INC.4
- Jul 29, 2025Granted 28,000 shares of ALUMIS INC.5
- Jul 1, 2024Granted 6,417 shares of ALUMIS INC.6
- Jul 1, 2024Returned to company 6,417 shares of ALUMIS INC.6
- Jul 1, 2024Granted 175,401 shares of ALUMIS INC.6
- Jul 1, 2024Returned to company 175,401 shares of ALUMIS INC.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARPharmacyclics, Board member
- 4
- 5SEC EDGARForm 4 filed Jul 31, 2025
- 6SEC EDGARForm 4 filed Jul 1, 2024